Tutsch KD - Search Results

1

Platinum analogue combination chemotherapy: cisplatin and carboplatin--a phase I trial with pharmacokinetic assessment of the effect of cisplatin administration on carboplatin excretion.

Trump DL, Grem JL, Tutsch KD, Willson JK, Simon KJ, Alberti D, Storer B, Tormey DC. Trump DL, et al. Among authors: tutsch kd. J Clin Oncol. 1987 Aug;5(8):1281-9. doi: 10.1200/JCO.1987.5.8.1281. J Clin Oncol. 1987. PMID: 3040920

2

Phase I trial of 3-hour infusion of paclitaxel with or without granulocyte colony-stimulating factor in patients with advanced cancer.

Schiller JH, Storer B, Tutsch K, Arzoomanian R, Alberti D, Feierabend C, Spriggs D. Schiller JH, et al. J Clin Oncol. 1994 Feb;12(2):241-8. doi: 10.1200/JCO.1994.12.2.241. J Clin Oncol. 1994. PMID: 7509380 Clinical Trial.

3

Phase I clinical trial of a combination of dipyridamole and acivicin based upon inhibition of nucleoside salvage.

Willson JK, Fischer PH, Tutsch K, Alberti D, Simon K, Hamilton RD, Bruggink J, Koeller JM, Tormey DC, Earhart RH, et al. Willson JK, et al. Cancer Res. 1988 Oct 1;48(19):5585-90. Cancer Res. 1988. PMID: 3416311

4

Phase I trial of intravenous thymidine and carboplatin in patients with advanced cancer.

Robins HI, Tutsch K, Katschinski DM, Jacobson E, Mehta M, Olsen M, Cohen JD, Tiggelaar CL, Arzoomanian RZ, Alberti D, Feierabend C, Wilding G. Robins HI, et al. J Clin Oncol. 1999 Sep;17(9):2922-31. doi: 10.1200/JCO.1999.17.9.2922. J Clin Oncol. 1999. PMID: 10561372 Clinical Trial.

5

A phase I trial of 5-fluorouracil, leucovorin, and dipyridamole given by concurrent 120-h continuous infusions.

Bailey H, Wilding G, Tutsch KD, Arzoomanian RZ, Alberti D, Tombes MB, Grem JL, Spriggs DR. Bailey H, et al. Among authors: tutsch kd. Cancer Chemother Pharmacol. 1992;30(4):297-302. doi: 10.1007/BF00686299. Cancer Chemother Pharmacol. 1992. PMID: 1643698 Clinical Trial.

6

Pharmacokinetic and pharmacodynamic analysis of fluorouracil during 72-hour continuous infusion with and without dipyridamole.

Trump DL, Egorin MJ, Forrest A, Willson JK, Remick S, Tutsch KD. Trump DL, et al. Among authors: tutsch kd. J Clin Oncol. 1991 Nov;9(11):2027-35. doi: 10.1200/JCO.1991.9.11.2027. J Clin Oncol. 1991. PMID: 1941062

7

Phase I trial of 5-fluorouracil and dipyridamole administered by seventy-two-hour concurrent continuous infusion.

Remick SC, Grem JL, Fischer PH, Tutsch KD, Alberti DB, Nieting LM, Tombes MB, Bruggink J, Willson JK, Trump DL. Remick SC, et al. Among authors: tutsch kd. Cancer Res. 1990 May 1;50(9):2667-72. Cancer Res. 1990. PMID: 2328492

8

Inadvertent administration of 480 mg/m2 of cisplatin.

Schiller JH, Rozental J, Tutsch KD, Trump DL. Schiller JH, et al. Among authors: tutsch kd. Am J Med. 1989 May;86(5):624-5. doi: 10.1016/0002-9343(89)90402-6. Am J Med. 1989. PMID: 2712074 No abstract available.

9

Phase I trial of hepatic artery infusion of 5-iodo-2'-deoxyuridine and 5-fluorouracil in patients with advanced hepatic malignancy: biochemically based combination chemotherapy.

Remick SC, Benson AB 3rd, Weese JL, Willson JK, Ramirez G, Wirtanen GW, Alberti DB, Nieting LM, Tutsch KD, Fischer PH, et al. Remick SC, et al. Among authors: tutsch kd. Cancer Res. 1989 Nov 15;49(22):6437-42. Cancer Res. 1989. PMID: 2804987

10

Methotrexate and dipyridamole combination chemotherapy based upon inhibition of nucleoside salvage in humans.

Willson JK, Fischer PH, Remick SC, Tutsch KD, Grem JL, Nieting L, Alberti D, Bruggink J, Trump DL. Willson JK, et al. Among authors: tutsch kd. Cancer Res. 1989 Apr 1;49(7):1866-70. Cancer Res. 1989. PMID: 2924325

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters